Physician
Pediatric Hematology & Oncology
Dr. Judith G. Villablanca, MD
|
|
Give Review
Judith G. Villablanca, MD works in the field of Pediatric Hematology & Oncology. He went to medical school at University of Michigan Medical School. He over the years received 1 awards: "Super Doctor". Judith Villablanca is a published doctor and has 53 publications published. The lastest was: 'Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.'
Publications
- Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
- (131)I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Ther...
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
- Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches t...
- Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children's Oncology Group.
- Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma.
- Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial.
- The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
- Choroid plexus tumors; management, outcome, and association with the Li-Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991-2010.
- Phase II Study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: A report from the Child...
- A phase I study of zoledronic acid and low-dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study.
- Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.
- Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
- Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
- Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neurob...
- Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therap...
- Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study.
- Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.
- Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncol...
- Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a n...
- A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
- Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas.
- Approaches to treatment for extraocular retinoblastoma: Children's Hospital Los Angeles experience.
- Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary.
- Viridans streptococcal shock in bone marrow transplantation patients.
- Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children''s Cancer Group results.
- Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study.
- Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.
- Surveillance imaging in children with medulloblastoma (posterior fossa PNET).
- Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by...
- Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
- Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
- A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma.
- Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation.
- Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Cen...
- Chemotherapy plus local treatment in the management of intraocular retinoblastoma.
- Esthesioneuroblastoma in the pediatric age-group: the role of chemotherapy and autologous bone marrow transplantation.
- Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.
- Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.
- Bone abnormalities detected with skeletal scintigraphy after bone marrow harvest in patients with childhood neuroblastoma.
- Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir ...
- Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
- The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients.
- Ontogeny of normal human B-cell and T-cell precursors and its relation to leukemogenesis.
- Differentiation of normal human pre-B cells in vitro.
- Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
- Expression of interleukin-4 receptors on early human B-lineage cells.
- Multiparameter flow cytometric analysis of human fetal bone marrow B cells.
- Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
- Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children''s Oncology Group.
- Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children''s Oncology Group (CCG 09709).
- Retinoid therapy of high-risk neuroblastoma.
Schools
University Of Michigan Medical School
UCLA Hosps Clins
University Mn
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Access Plus Savenet
- Basic PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Molina Healthcare
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Super Doctor
Education
-
UCLA Medical Center -
University of Michigan Medical School
Hospital
-
Children's Hospital Los Angeles
Helpful Reviews
Similar Doctors
|
|
Dr. Roy L. Kao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Seeger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brigitte N. Gomperts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Girish Dhall, MB
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|